Clinical Trial Update: INTERVENE: Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events [NA]

View source ↗

Summary

Clinical trial INTERVENE investigating endocardial ventricular substrate ablation for preventing recurrent ventricular tachycardia events has been terminated; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventricular Tachycardia

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Ventricular Tachycardia | NA | Status: TERMINATED | Results posted: 2020-01-27